Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 100,817 |
|
|||||
| News | - | ||||||
| Day High | 0.66 | Low High |
|||||
| Day Low | 0.582 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Viracta Therapeutics Inc | VIRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0189 | -2.98% | 0.616 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.64 | 0.582 | 0.66 | 0.616 | 0.6349 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 340 | 100,817 | $ 0.6177736 | $ 62,282 | - | 0.43 - 1.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 200 | $ 0.616 | USD |
Viracta Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 23.96M | 39.27M | - | 0 | -51.06M | -1.30 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Viracta Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VIRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.681 | 0.75 | 0.50 | 0.5705723 | 220,823 | -0.065 | -9.54% |
| 1 Month | 0.83 | 0.8938 | 0.50 | 0.6608274 | 106,542 | -0.214 | -25.78% |
| 3 Months | 0.9657 | 1.31 | 0.50 | 0.8669089 | 105,550 | -0.3497 | -36.21% |
| 6 Months | 0.50 | 1.31 | 0.43 | 0.7180225 | 120,414 | 0.116 | 23.20% |
| 1 Year | 1.69 | 1.77 | 0.43 | 0.8865389 | 119,587 | -1.07 | -63.55% |
| 3 Years | 10.17 | 13.08 | 0.43 | 3.82 | 177,908 | -9.55 | -93.94% |
| 5 Years | 16.76 | 18.24 | 0.43 | 4.80 | 193,720 | -16.14 | -96.32% |
Viracta Therapeutics Description
| Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. |
